Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Baxter
Cipla
Covington
Accenture
Citi
Cantor Fitzgerald
Daiichi Sankyo
McKinsey

Generated: May 20, 2018

DrugPatentWatch Database Preview

ALFENTANIL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Alfentanil, and when can generic versions of Alfentanil launch?

Alfentanil is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in ALFENTANIL is alfentanil hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the alfentanil hydrochloride profile page.
Drug patent expirations by year for ALFENTANIL
Pharmacology for ALFENTANIL
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for ALFENTANIL
Synonyms for ALFENTANIL
1N74HM2BS7
5-26-13-00110 (Beilstein Handbook Reference)
70879-28-6 (hydrochloride)
71195-58-9
77009-EP2275420A1
77009-EP2280008A2
77009-EP2298764A1
77009-EP2298765A1
77009-EP2308509A1
AC1L1ARM
AC1Q6F0S
afentanyl
Alfenta
Alfenta (TN)
Alfentanil (INN)
Alfentanil [INN:BAN]
Alfentanilum
Alfentanilum [INN-Latin]
Alfentanyl
BDBM83450
BRN 1188293
C08005
CHEBI:2569
CHEMBL634
cid_64761
D07122
D0G5QB
DB00802
DEA No. 9737
DTXSID9022570
Epitope ID:153516
GTPL7108
HSDB 6789
IDBPHNDTYPBSNI-UHFFFAOYSA-N
KB-309424
L001231
LS-119259
MLS002320667
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)-N-phenylpropionamid
N-(1-(2-(4-Ethyl-4,5-dihydro-5-oxotetrazolyl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilid
N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide
N-[1-(2-(4-Ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropionamide
N-[1-[2-(4-ethyl-5-keto-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]-N-phenyl-propionamide;hydrochloride
N-[1-[2-(4-ethyl-5-oxidanylidene-1,2,3,4-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenyl-propanamide;hydrochloride
N-[1-[2-(4-ethyl-5-oxo-1-tetrazolyl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide;hydrochloride
N-[1-[2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide
N-[1-[2-(4-Ethyl-5-oxo-4,5-dihydro-1H-tetraazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide #
N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide
N-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl]-N-phenylpropanamide;hydrochloride
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-1,2,3,4-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)piperidin-4-yl}-N-phenylpropanamide
N-{1-[2-(4-ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-[(methyloxy)methyl]piperidin-4-yl}-N-phenylpropanamide
NCGC00247354-01
NCGC00247354-02
Propanamide, N-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl)-4-(methoxymethyl)-4-piperidinyl)-N-phenyl-
R-39209
Rapifen
Rapifen (TN)
SCHEMBL26256
SMR001338813
UNII-1N74HM2BS7
ZINC601281

US Patents and Regulatory Information for ALFENTANIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira ALFENTANIL alfentanil hydrochloride INJECTABLE;INJECTION 075221-001 Oct 28, 1999 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Moodys
Merck
Queensland Health
Argus Health
Dow
Harvard Business School
Express Scripts
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.